Quick Answer
GRI Bio, Inc. reported Total Assets of $8.67 million for fiscal year 2025.
GRI Bio, Inc. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $8.67M | +51.0% |
| 2024 | $5.74M | +94.1% |
| 2023 | $2.96M | +671.8% |
| 2022 | $383.0K | -95.4% |
| 2021 | $8.34M | +772.8% |
| 2020 | $955.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.78M | -12.4% | -15.7% |
| June 30, 2025 | $5.67M | -19.3% | +40.4% |
| March 31, 2025 | $4.04M | -11.9% | -29.6% |
| December 31, 2024 | $5.74M | +94.1% | +5.1% |
| September 30, 2024 | $5.46M | +24.0% | -22.4% |
| June 30, 2024 | $7.03M | +24.6% | +53.3% |
| March 31, 2024 | $4.59M | +118.7% | +55.2% |
| December 31, 2023 | $2.96M | +671.8% | -32.9% |
- GRI Bio, Inc. showed an increase of +51.0% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, GRI Bio, Inc.’s total assets has grown by 807.4% (from $955.0 thousand to $8.67 million).
- The most recent figure is from GRI Bio, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on January 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: